Systemic Atg7 ablation in FSF-KRasG12D; Trp53 frt/frt-driven lung cancer mice increased their susceptibility to infection and neurodegeneration, thus limiting their survival up to 2–3 months; however, tumor growth decreased before the destruction of normal tissues [47]. This evidence concerns the gene ATG7 and lung cancer.